HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47 | -21.7% | 11,000 | 0.0% | 0.00% | – |
| Q2 2023 | $60 | +30.4% | 11,000 | 0.0% | 0.00% | – |
| Q1 2023 | $46 | -2.1% | 11,000 | -35.3% | 0.00% | – |
| Q4 2022 | $47 | -99.9% | 17,000 | 0.0% | 0.00% | – |
| Q3 2022 | $44,000 | -29.0% | 17,000 | 0.0% | 0.00% | – |
| Q2 2022 | $62,000 | -41.5% | 17,000 | 0.0% | 0.00% | – |
| Q1 2022 | $106,000 | -11.7% | 17,000 | 0.0% | 0.00% | – |
| Q4 2021 | $120,000 | +0.8% | 17,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $119,000 | -16.2% | 17,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $142,000 | +52.7% | 17,000 | 0.0% | 0.00% | – |
| Q1 2021 | $93,000 | +27.4% | 17,000 | 0.0% | 0.00% | – |
| Q4 2020 | $73,000 | +43.1% | 17,000 | 0.0% | 0.00% | – |
| Q3 2020 | $51,000 | -3.8% | 17,000 | 0.0% | 0.00% | – |
| Q2 2020 | $53,000 | -13.1% | 17,000 | +61.1% | 0.00% | -100.0% |
| Q1 2015 | $61,000 | – | 10,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |